Focus and Scope

The Journal of Commercial Biotechnology is the definitive international quarterly publication for bioscience business professionals. The Journal is designed specifically for those professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up-to-date with the current issues and industry trends.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

• Management
• Policy
• Finance
• Law
• Regulation
• Bioethics

Submissions may be in the form of:

• Research-based investigations
• Trends and best practices
• Case studies
• Commentaries
• Policy analysis
• Bioethics
• Market analysis
• Legal and regulatory updates

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers, within this fast moving field.

Every issue of Journal of Commercial Biotechnology publishes forward-thinking regular features from some of the leading names in biotechnology commercialisation.

By subscribing to Journal of Commercial Biotechnology, you will have access to the latest intelligence on cutting-edge life science research commercialisation, worldwide:

• Peer-reviewed papers - original, high-quality articles from leading practitioners on the latest thinking, developments and techniques affecting biopharmaceutical, agrochemical and environmental companies
• Legal & regulatory updates - providing expert guidance on the major legal and regulatory issues affecting the industry, compiled and prepared by Bird & Bird and Reed Smith
• Financial account reports - summarizing the finances of the major established and newly-formed biotech companies
• Book reviews - previewing forthcoming books in life science commercialisation

The Journal of Commercial Biotechnology is essential reading for:

• CEOs
• Directors
• Presidents
• Vice Presidents
• Heads of Business Development
• Heads of Corporate Development
• Commercial Directors
• Chief Financial Officers
• Investment Managers
• Heads of Corporate Intellectual Property
• Heads of Regulatory Affairs
• Intellectual Property Lawyers and all those involved in the commercialisation of biotechnology.

Section Policies

Editorial

This section is only for editors.

Open Submissions

Indexed

Peer Reviewed

Commentary

Open Submissions

Indexed

Peer Reviewed

Articles

Open Submissions

Indexed

Peer Reviewed

From the Classroom

Editors

• Arlen Meyers

Open Submissions

Indexed

Peer Reviewed

Intellectual Property Management

Open Submissions

Indexed

Peer Reviewed

Case Study

Open Submissions

Indexed

Peer Reviewed

From the Boardroom

Open Submissions

Indexed

Peer Reviewed

Legal and Regulatory Updates

Open Submissions

Indexed

Peer Reviewed

Conference Report

Reports on biotechnology conferences and events.

Open Submissions

Indexed

Peer Reviewed

Special Section

Reserved for special issues or special sections based on predetermined themes.

Open Submissions

Indexed

Peer Reviewed

Book Reviews

Open Submissions

Indexed

Peer Reviewed

Peer Review Process

All papers submitted for publication will be subject to a double-blind refereeing procedure. Authors should be aware that papers submitted to the Journal should not be simultaneously submitted for review to any other publications.

 

Publication Frequency

The Journal of Commercial Biotechnology is published quarterly, with issues in January, April, July, and October of each year.

Deadlines are four months ahead of each publication date.

Journal of Commercial Biotechnology Deadlines:

Publication Date	Submission Deadline
January	prior September
April	prior December
July	prior March
October	prior June

Author Rights

As an author you retain many rights. In the following cases specific permission is not required, although you should cite the journal's copyright and give a full bibliographic reference.

You have the right to:

• reuse figures and tables from your contribution in other work prepared by yourself
• make copies without charge of your contribution for personal use, including for personal classroom teaching use. This does not include inclusion in course pack material for sale by libraries and institutions
• make and distribute a small number (i.e. not by bulk email) copies of your contribution to colleagues for their personal use
• present your contribution at a meeting or conference and distribute copies to individuals attending the meeting
• use the contribution or any part thereof in a printed compilation of works of the author, such as collected writings or lecture notes
• prepare other derivative works, extend the contribution into book-length form, or otherwise re-use portions or excerpts in other works authored by you

Authors may also upload their contribution to institutional or personal web pages, but must ensure that public availability is delayed until 18 months after first online publication in the journal.

An acknowledgement with a link to the Journal of Commercial Biotechnology website should be included, as in the following example:

“This paper was published in the Journal of Commercial Biotechnology at http://CommercialBiotechnology.com”

Open / Subscription-Based Access

The Journal of Commercial Biotechnology uses a hybrid subscription-based and open access model, serving authors and readers preferring either option.

More details are available at the Open Access Option page.

Reprints

Full-color reprints of journal articles are available at any time. For more information, see the Reprints Page.